LOADING
Comparing Merck & Company (MRK) and Cisco Systems (CSCO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | CSCO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $281.2B | $471.2B |
| P/E Ratio | 32.1 | 39.9 |
| Forward P/E | 22.5 | 25.2 |
| PEG Ratio | 5.29 | 1.66 |
| EPS | $3.55 | $3.00 |
| Revenue Growth (YoY) | 4.9% | 12.0% |
| Profit Margin | 13.6% | 19.7% |
| Return on Equity | 18.9% | 25.2% |
| Dividend Yield | 2.84% | 1.41% |
| Beta | 0.22 | 1.00 |
| 52-Week High | $123.33 | $130.37 |
| 52-Week Low | $74.18 | $64.66 |
| Volume | -- | -- |
Cisco Systems is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Cisco Systems has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.